首页> 外文期刊>EFSA Journal >Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus paracasei CNCM I‐1688 and Lactobacillus salivarius CNCM I‐1794 and reduction of gastro‐intestinal discomfort (ID 2972), decreasing potentially pathogenic gastro‐intestinal microorganisms (ID 2972), improved lactose digestion (ID 2972) and increasing IL‐10 production (ID 2973) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
【24h】

Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus paracasei CNCM I‐1688 and Lactobacillus salivarius CNCM I‐1794 and reduction of gastro‐intestinal discomfort (ID 2972), decreasing potentially pathogenic gastro‐intestinal microorganisms (ID 2972), improved lactose digestion (ID 2972) and increasing IL‐10 production (ID 2973) (further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

机译:关于证实与副干酪乳杆菌CNCM I-1688和唾液乳杆菌CNCM I-1794联合使用和减少胃肠道不适(ID 2972​​),减少潜在致病性胃肠道微生物(ID 2972​​)有关的健康主张的科学意见,根据1924/2006号法规(EC)第13(1)条,改善了乳糖消化(ID 2972​​)并提高了IL-10产量(ID 2973)(进一步评估)

获取原文
       

摘要

Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to provide a scientific opinion on health claims pursuant to Article 13 of Regulation (EC) No 1924/2006 in the framework of further assessment related to a combination of Lactobacillus paracasei CNCM I‐1688 and Lactobacillus salivarius CNCM I‐1794 and reduction of gastro‐intestinal discomfort, decreasing potentially pathogenic gastro‐intestinal microorganisms, improved lactose digestion and increasing IL‐10 production. The food constituent that is the subject of the health claims, a combination of L. paracasei CNCM I‐1688 and L. salivarius CNCM I‐1794, is sufficiently characterised. The evidence provided did not establish that the proposed claimed effect, increasing IL‐10 production, is a beneficial physiological effect. On the basis of the data presented, the Panel concludes that a cause and effect relationship has not been established between the consumption of a combination of L. paracasei CNCM I‐1688 and L. salivarius CNCM I‐1794 and a beneficial physiological effect related to an increase in IL‐10 production. The claimed effect, reduction of gastro‐intestinal discomfort, is a beneficial physiological effect for the general population. The claimed effect, decreasing potentially pathogenic gastro‐intestinal microorganisms, might be a beneficial physiological effect for the general population. The claimed effect, improved lactose digestion, is a beneficial physiological effect for individuals with lactose maldigestion. No human intervention studies were provided from which conclusions could be drawn for the scientific substantiation of the above‐mentioned claims. On the basis of the data provided, the Panel concludes that a cause and effect relationship has not been established between the consumption of a combination of L. paracasei CNCM I‐1688 and L. salivarius CNCM I‐1794 and reduction of gastro‐intestinal discomfort, decreasing potentially pathogenic gastro‐intestinal microorganisms and improved lactose digestion.
机译:应欧洲委员会的要求,要求营养产品,营养和过敏问题专家组(NDA)根据与欧盟有关的进一步评估框架,根据1924/2006号法规(EC)第13条,就健康声明提供科学意见。结合使用副干酪乳杆菌CNCM I-1688和唾液乳杆菌CNCM I-1794并减少肠胃不适,减少潜在致病性肠胃微生物,改善乳糖消化和增加IL-10产量。作为健康要求主题的食品成分,已经充分表征了副干酪乳杆菌CNCM I-1688和唾液乳杆菌CNCM I-1794的组合。所提供的证据并未证明所提议的增加IL-10产生的作用是有益的生理作用。根据提供的数据,小组得出结论,食用副干酪乳杆菌CNCM I-1688和唾液乳杆菌CNCM I-1794的组合与与之相关的有益生理效应之间尚未建立因果关系IL-10产量增加。声称的效果(减少胃肠不适)是对普通人群有益的生理效果。所声称的作用,减少潜在致病性的胃肠道微生物,可能是对一般人群有益的生理作用。所要求的效果,即改善的乳糖消化,对于患有乳糖消化不良的个体是有益的生理效果。没有提供任何人为干预研究,可以从中得出结论以对上述主张进行科学证实。根据提供的数据,小组得出结论,食用副干酪乳杆菌CNCM I-1688和唾液乳杆菌CNCM I-1794的组合与减少肠胃不适之间尚无因果关系,减少潜在的致病性胃肠道微生物,改善乳糖消化。

著录项

  • 来源
    《EFSA Journal》 |2012年第8期|共20页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类 食品工业;
  • 关键词

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号